LXRX
Lexicon Pharmaceuticals Inc
Price:  
0.73 
USD
Volume:  
5,842,167.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX WACC - Weighted Average Cost of Capital

The WACC of Lexicon Pharmaceuticals Inc (LXRX) is 7.6%.

The Cost of Equity of Lexicon Pharmaceuticals Inc (LXRX) is 8.55%.
The Cost of Debt of Lexicon Pharmaceuticals Inc (LXRX) is 7.00%.

Range Selected
Cost of equity 6.20% - 10.90% 8.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.9% - 9.4% 7.6%
WACC

LXRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 1.07
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 10.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.36 0.36
Cost of debt 7.00% 7.00%
After-tax WACC 5.9% 9.4%
Selected WACC 7.6%